Genomics

Biomarkers of relapse and therapeutic response in addictions and mood disorders

Main field of research: 

Neurological and psychiatric diseases

Keywords: 

addiction
Mood disorders
Neuropsychophamarcology
Genomics
Biomarkers

ENP label: 

2015

Research Center / Institute: 

UMR-S 1144 Therapeutic Optimisation in Neuropsychopharmacology

Research Unit Code: 

UMRS 1144

The "Biomarkers of relapse and therapeutic response in addictions and mood disorders" team develops research on mood disordersand addiction both at the clinical and fundamental level (ranked A, AERES 2013, creation 01/01/2014).The objective is to identifyclinical, biological, genetic or imaging-based markers of the response to psychotropic drugs (in the context of drug abuse or during thetreatment for mood disorders or pain management). These markers will allow us to better predict the response (therapeutic and sideeffects) in order to improve the therapeutic monitoring of patients.

Leader

Leader: 

Personal

Team members: 

Marie-Claire CYNTHIA
Jean-Louis LAPLANCHE
Jean-Pierre LEPINE
Emmanuel CURIS
Florence VORSPAN
Vanessa BLOCH
Frank QUESTEL
Sarah SPORTICHE
Gaël DUPUY
Institutions

Principal Institution: 

Inserm

Affiliated institutions: 

Université Paris Descartes
Université Paris Diderot

Doctoral School: 

ED 436
Laboratory

Surname: 

Variabilité de réponses aux psychotropes
Publications

Publications: 

Geoffroy PA# , Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, Bellivier F# , Etain B. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand. 2014 28.

Bellivier F#, Geoffroy PA#, Etain B, Scott J. Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder. Expert Opin Ther Targets. 2015 Mar 2:1-17.

Boudebesse C, Geoffroy PA# , Henry C, Germain A, Scott J, Lajnef M, Leboyer M, Bellivier F# , Etain B. Eur Psychiatry. 2014 4.

Mouly S, Bloch V, Peoc'h K, Houze P, Labat L, Ksouda K, Simoneau G, Declèves X, Bergmann JF, Scherrmann JM, Laplanche JL#, Lepine JP#, Vorspan F#. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. Br J Clin Pharmacol. in press

Geoffroy PA# , Boudebesse C, Henrion A, Jamain S, Henry C, Leboyer M, Bellivier F# , Etain B. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study. Genes Brain Behav. 2014 13(3):299-304.